About the GeneSight Test
GeneSight is a pharmacogenomic test that analyzes clinically important genetic variations that may affect your outcomes with certain medications. The results of the test can show which medications may require dose adjustments, may be less likely to work, or may have an increased risk of side effects based on your genetic makeup. You can find more information about the GeneSight test at www.genesight.com/product.
GeneSight Psychotropic Clinical Studies
There are seven published peer-reviewed studies showing the clinical validity, clinical utility and economic utility of the GeneSight Psychotropic test. In the GUIDED study, patients in the GeneSight arm saw a 50% relative improvement in remission rates versus treatment as usual. You can learn more about the clinical evidence supporting the use of the GeneSight Psychotropic test at www.genesight.com/clinical-studies.
Cost of the GeneSight Test
Many commercial and government insurance plans reimburse for all or part of the cost of the GeneSight test. For patients with commercial insurance, there is also an opportunity to apply for the GeneSight Financial Assistance Program. You can learn more about the cost of the GeneSight test, the GeneSight Financial Assistance Program, and the GeneSight Interest-Free Payment plan at www.genesight.com/cost.
For more information, visit www.genesight.com.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.